Pfizer, Inc. has agreed to pay $23.85 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs, in violation of the False Claims Act, the Justice Department announced Thursday.   When a Medicare beneficiary obtains a prescription drug covered by Medicare Part B or…